Kliuk-Ben Bassat Orit, Brill Silviu, Sharon Haggai
Department of Nephrology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel.
Department of Anesthesiology and Critical Care Medicine, Tel Aviv Sourasky Medical Center, Tel Aviv University, Institute of Pain Medicine, Tel Aviv, Israel.
Hemodial Int. 2019 Oct;23(4):E104-E105. doi: 10.1111/hdi.12736. Epub 2019 Feb 8.
Significant chronic pain is highly prevalent in chronic kidney disease patients and is associated with morbidity and mortality. In this study, we retrospectively evaluated the incidence and treatment of pain in the dialysis unit of our tertiary referral center. The cohort included 147 patients. Over 66% reported significant (VAS >40) chronic pain during the preceding 3 months, most often characterized as stabbing (38%) and with concurrent itching (44%). Only 33% of patients received chronic pain medications, while 55.6% of patients with severe pain and 45.9% with pain characterized as the worst imaginable did not receive any analgesics. Pregabalin or weak opioids were the most frequently used. In conclusion, chronic pain is highly prevalent and markedly undertreated in dialysis patients, despite its significant adverse impact.
严重慢性疼痛在慢性肾脏病患者中极为普遍，且与发病率和死亡率相关。在本研究中，我们回顾性评估了我们三级转诊中心透析单元中疼痛的发生率及治疗情况。该队列包括147名患者。超过66%的患者报告在前3个月内存在严重（视觉模拟评分法>40）慢性疼痛，最常见的特征为刺痛（38%）并伴有瘙痒（44%）。仅33%的患者接受了慢性疼痛药物治疗，而55.6%的重度疼痛患者和45.9%将疼痛描述为难以想象的患者未接受任何镇痛药治疗。普瑞巴林或弱阿片类药物是最常用的药物。总之，尽管慢性疼痛具有显著的不良影响，但在透析患者中极为普遍且明显治疗不足。
